Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. - Wikidata - awgldk - TriplyDB

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

http://www.wikidata.org/entity/Q43926526

about

Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias Transgenic analysis of the role of FKBP12.6 in cardiac function and intracellular calcium release Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks In situ modulation of the human cardiac ryanodine receptor (hRyR2) by FKBP12.6 Androgen receptor (AR) in cardiovascular diseases FK506-binding protein 1b/12.6: a key to aging-related hippocampal Ca2+ dysregulation?Effects of biological sex on the pathophysiology of the heart Dysregulated ryanodine receptors mediate cellular toxicity: restoration of normal phenotype by FKBP12.6 Localization of the 12.6-kDa FK506-binding protein (FKBP12.6) binding site to the NH2-terminal domain of the cardiac Ca2+ release channel (ryanodine receptor)Interaction of FKBP12.6 with the cardiac ryanodine receptor C-terminal domain Distinct pathways involving the FK506-binding proteins 12 and 12.6 underlie IL-2-versus IL-15-mediated proliferation of T cells Dissociation of FKBP12.6 from ryanodine receptor type 2 is regulated by cyclic ADP-ribose but not beta-adrenergic stimulation in mouse cardiomyocytes Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1 RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice.FKBP12.6-knockout mice display hyperinsulinemia and resistance to high-fat diet-induced hyperglycemia FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes Mechanistic Pathways of Sex Differences in Cardiovascular Disease.Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice.Identification and comparative analysis of sixteen fungal peptidyl-prolyl cis/trans isomerase repertoires.FKBP12.6 overexpression decreases Ca2+ spark amplitude but enhances [Ca2+]i transient in rat cardiac myocytes.Modification of sarcoplasmic reticulum (SR) Ca2+ release by FK506 induces defective excitation-contraction coupling only when SR Ca2+ recycling is disturbed.ERβ selective agonist inhibits angiotensin-induced cardiovascular pathology in female mice Influence of sex hormones and phytoestrogens on heart disease in men and women ROS-dependent signaling mechanisms for hypoxic Ca(2+) responses in pulmonary artery myocytes.Pin1 deficiency causes endothelial dysfunction and hypertension.Mechanisms of sudden cardiac death.A simple and efficient route to the FKBP-binding domain from rapamycin FKBP12 activates the cardiac ryanodine receptor Ca2+-release channel and is antagonised by FKBP12.6.Estrogen receptor-beta prevents cardiac fibrosis.17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload Excitation-contraction coupling gain and cooperativity of the cardiac ryanodine receptor: a modeling approach.Three-dimensional visualization of FKBP12.6 binding to an open conformation of cardiac ryanodine receptor The ryanodine receptor in cardiac physiology and disease.Functional role of Calstabin2 in age-related cardiac alterations.FK506 binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension.Regulation of Ryanodine Receptor Ion Channels Through Posttranslational Modifications.Regulation of cardiac excitation-contraction coupling by action potential repolarization: role of the transient outward potassium current (I(to)).The therapeutic potential of new insights into myocardial excitation-contraction coupling.

P2860

Q24296752-28875B94-526E-490D-BEF5-537BEA18AF38 Q24297573-63C7B702-1D0F-463E-9D05-41B1356234D9 Q24308765-7CA60256-3B7B-4CE8-BA03-1C9473BC29AB Q24319719-0238A73A-FFFA-4C9E-BBC6-5B8F5C9985E4 Q26771962-0954D20F-56C6-41F7-8BC3-4544A81D19B1 Q26852281-BC5FCE2D-A4F4-4870-8DC7-80A7A8D36371 Q26866520-804EE034-1FF0-4F44-9F91-8FFB73CB2E5C Q28204837-4CCDA76B-5E5C-4823-AC38-E609B8BEB91E Q28215774-234EBD6D-FA39-4783-AE6E-9554EC1C5662 Q28297732-97D0AE2F-B431-4764-9936-1C9079A9304E Q28509199-8689B1AD-5566-4A34-855D-00A36A447921 Q28512354-7615AE1C-479E-431A-98B6-84E8B67F2E89 Q28568314-394F80CF-3FE7-4599-899C-9C47FDD1A80C Q28590035-73C89215-18FB-4100-8BC7-68FB9D81E361 Q28591790-FAF0D9DF-C53B-4910-A6DA-3093C5B322CC Q28592360-1359DB02-B3DA-471F-95E9-12F3692C60CA Q28593597-67394122-FB08-437E-A469-6B5AA9F0CBD3 Q28594881-6699BC16-BD6B-477C-84C2-B10361B94501 Q30241924-4EABF218-FB2A-40B7-ADB7-45EA1DB9F7B1 Q30497498-2BA0FD8C-3D57-420F-9115-36C0FAB4730C Q30826128-DC651EAC-AF48-4270-840C-E7D35EC5322B Q31098133-272E86CD-B19B-46DD-A530-42A0124014BB Q33214744-A784FDE0-6107-4709-B5C2-F4E78F8E9EAD Q33584903-9E1A0AEF-C65B-494D-B9C9-76E54A0FBF02 Q33721061-9983962B-F586-4893-845F-38AE3283FF22 Q33818152-8EA9AE6C-9D83-4EC5-A45C-0DCADAC2D43A Q33896672-6AC94B83-D62E-448B-B7D4-11955D861360 Q33930892-F21F7717-E22F-465F-A6DD-A4E8F6BF6884 Q34011666-E874781A-CE1B-4A5D-8383-8847F192A314 Q34171525-BCD5083D-9443-41DB-8272-746D0E9E30BE Q34220113-34A2DC85-244D-4867-BF9C-72AF4C4DF5CC Q34274447-475FF355-880D-4164-A871-60C2A3128B4E Q34351644-CB9249FE-2676-4966-849E-198B1283A798 Q34352742-E967EACA-62A9-4883-9019-023262F10FDD Q34505314-56774304-9DB4-43C8-914A-29367682A48C Q34675791-CC47A114-B44B-4F35-936B-68EE90361BB9 Q35024911-39B1C41C-36AD-42BC-BAA9-7472D367C4A5 Q35033112-54B53DC1-22A6-45E9-8AC9-796143B62996 Q35037535-022AFE55-1385-4FFA-9261-4F855F013473 Q35086109-656225DC-A3A6-46B6-9FDC-4A6446773DFA

P2860

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

http://www.wikidata.org/entity/Q43926526

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

@en

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

@nl

type

label

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

@en

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

@nl

prefLabel

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

@en

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

@nl

P1433

Q43926526-6E05B010-F663-46C9-AB5A-85B18D7014E5

P1476

Q43926526-CDC42831-2A8C-4C49-9B04-6D76C0BC051D

P2093

Q43926526-00ED8500-DC88-4825-B841-7690008986C2

Q43926526-56DE1110-D982-465F-A0A8-DEB37CE6BB20

Q43926526-65F1E21D-6F26-4546-B120-2B3C3DAB57EE

Q43926526-75007AC7-A8D4-4C21-B80F-1BDED6669F89

Q43926526-7836EC24-F47B-4EF1-A0D8-6CF1E20FF8AA

Q43926526-7CB53C34-CA6C-467B-9BFD-90D0C3C2A73E

Q43926526-8485B47E-F213-445C-BB46-7D374396D416

Q43926526-970D7372-B250-4FCC-A4A5-66D8B542030E

Q43926526-B2A571B2-3FFC-4AF1-9593-D57C6CF5D0FA

Q43926526-BF8A3098-6C5B-4015-91AE-C53709D60917

P2888

Q43926526-807C052D-01CB-4B2E-B4E7-56D743F0CCA5

P304

Q43926526-D8AB999E-6559-484A-A975-835DC4122ADD

P31

Q43926526-9DB1F4B1-C83F-4AC7-A603-CAFF19B8D0AD

P356

Q43926526-AED9053A-857A-4E26-8277-7E21EB566B57

P407

Q43926526-EE896F4B-441A-42D4-9C7D-B0147908E42C

P433

Q43926526-86EC8F86-B6E9-4121-8B40-D9504C87961E

P478

Q43926526-B405D8AA-AE4B-42D3-BA32-6A04E034221F

P50

Q43926526-9A7EC1AF-FAFC-48E8-BDF3-1A0D68D97D65

P577

Q43926526-A19BFE6A-F1FB-4FC6-B364-C7E4B6B4585B

P6179

Q43926526-7687C776-819E-454B-A7AA-20A183D831A0

P698

Q43926526-C852FF86-7CAB-47C6-804F-42E7D09B8DEB

P356

P1433

P1476

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

@en

P2093

Dong-Sheng Cheng

http://www.w3.org/2001/XMLSchema#string

Guang-Ju Ji

http://www.w3.org/2001/XMLSchema#string

Hong-Bo Xin

http://www.w3.org/2001/XMLSchema#string

Julio A Copello

http://www.w3.org/2001/XMLSchema#string

Ke-Yu Deng

http://www.w3.org/2001/XMLSchema#string

Loice H Jeyakumar

http://www.w3.org/2001/XMLSchema#string

Mei Lin Collier

http://www.w3.org/2001/XMLSchema#string

Michael I Kotlikoff

http://www.w3.org/2001/XMLSchema#string

Sidney Fleischer

http://www.w3.org/2001/XMLSchema#string

Tadashi Inagami

http://www.w3.org/2001/XMLSchema#string

P2888

P304

334-338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/416334A

http://www.w3.org/2001/XMLSchema#string

P407

P433

6878

http://www.w3.org/2001/XMLSchema#string

P478

416

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1044156002

http://www.w3.org/2001/XMLSchema#string

P698

11907581

http://www.w3.org/2001/XMLSchema#string